Selected Publications
Rajdev L, Lensing S, Ramos JC, Baiocchi R, Wang CC, Ratner L, Rubinstein P, Ambinder R, Henry DH, Lee M, Streicher H, Little RF, Chiao11 E, Dittmer DP, Einstein MH, Sparano JA, Mitsuyasu R: AMC 095: A REPORT OF NIVOLUMAB (NIVO) IN ADVANCED HIV ASSOCIATED SOLID TUMORS (ST) ESMO 2020 : 2020.
Henry D: Darbepoetin Alfa for Chemotherapy-Induced Anemia Among Patients With Advanced NSCLC PracticeUpdate website : 2020.
Li S, Peng Y, Liu J, Li S, Raskin L, Kelsh M, Zaha R, Gawade P, Henry DH, Lyman G: Variations in hospitalization and emergency department/observation stays using the oncology care model methodology in Medicare data Current Medical Research and Opinion : 2020.
Bryer EJ, Kallan MJ, Chiu TS, Scheuba KM, Henry DH: A retrospective analysis of venous thromboembolism trends inchemotherapy-induced anemia: Red blood cell transfusionversus erythrocyte stimulating agent administration EJHaem : 2020.
Gascón P, Nagarkar R, Šmakal M, Syrigos KN, Barrios CH, Sánchez JC, Zhang L, Henry DH, Gordon D, Hirsh V, Kubota K, Orlov S, Thomas G, Steinmetz T, Kang JH, Tomita DK, Fleishman AN, Park JK, De Oliveira Brandao C: A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin alfa for Chemotherapy-Induced Anemia in Patients With Advanced Non-Small Cell Lung Cancer J Thorac Oncol 15 : 190-202,2020.
Bryer EJ, Kallan MJ, Chiu TS, Scheuba KM, Henry DH: A Retrospective Analysis of Venous Thromboembolism Trends in Chemotherapy-Induced Anemia: Red Blood Cell Transfusion Versus Erythrocyte Stimulating Agent Administration eJHaem : 2020.
Bryer EJ, Kallan MJ, Chiu TS, Scheuba KM, Henry DH: A Retrospective Analysis of Venous Thromboembolism Trends in
Chemotherapy-Induced Anemia: Red Blood Cell Transfusion Versus
Erythrocyte Stimulating Agent Administration ASCO : 2020.
Henry D, Glaspy J, Harup R, Mittleman M, Zhou A, Bradley C, Saha G, Bartels P, Leong R, Yu KH: Roxadustat (FG4592; ASP1517; AZD9941) in the Treatment of
Anemia in Patients with Lower Risk Myelodysplastic Syndrome
(LR-MDS) and Low Red Blood Cell (RBC) Transfusion Burden (LTB) American Society of Hematology Meeting : Orlando, FL,2019.
Woodward C, Henry D.: Antiosteolytic Agent Use in Solid Tumor Bone Metastases ESMO-MAP : London,2019.
Byrer E, Kallan M, Chiu T, Scheuba K, Henry D.: A Retrospective Analysis of Venous Thromboembolism Trends in Chemotherapy-Induced Anemia: RBC Transfusion vs Erythrocyte Stimulating Agent Poster, ESCO-MAP : London,2019.
Academic Contact Information
Penn Hematology/Oncology
Abramson Cancer Center
Pennsylvania Hospital, Farm Journal Building
230 West Washington Square
Philadelphia,
PA
19106
Phone: 215-829-6088
Patient appointments: 800-789-7366